Eloxx Pharmaceuticals Inc (ELOX)

Currency in USD
0.040
0.000(0.00%)
Delayed Data·
ELOX Scorecard
Full Analysis
Stock has taken a big hit over the last week
ELOX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0400.040
52 wk Range
0.0010.750
Key Statistics
Prev. Close
-
Open
0.04
Day's Range
0.04-0.04
52 wk Range
0.001-0.75
Volume
-
Average Volume (3m)
2.39K
1-Year Change
-94.29%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELOX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Eloxx Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Eloxx Pharmaceuticals Inc Company Profile

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

Compare ELOX to Peers and Sector

Metrics to compare
ELOX
Peers
Sector
Relationship
P/E Ratio
0.0x−0.3x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
0.0x1.7x3.3x
Upside (Analyst Target)
0.0%177.2%45.1%
Fair Value Upside
Unlock18.2%7.4%Unlock

Earnings

Latest Release
Nov 13, 2023
EPS / Forecast
-1.31 / -1.97
Revenue / Forecast
-- / 900.00K
EPS Revisions
Last 90 days

ELOX Income Statement

FAQ

What Stock Exchange Does Eloxx Pharma Trade On?

Eloxx Pharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Eloxx Pharma?

The stock symbol for Eloxx Pharma is "ELOX."

What Is the Eloxx Pharma Market Cap?

As of today, Eloxx Pharma market cap is 132.02K.

What Is Eloxx Pharma's Earnings Per Share (TTM)?

The Eloxx Pharma EPS (TTM) is -8.81.

From a Technical Analysis Perspective, Is ELOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Eloxx Pharma Stock Split?

Eloxx Pharma has split 3 times.

How Many Employees Does Eloxx Pharma Have?

Eloxx Pharma has 18 employees.

What is the current trading status of Eloxx Pharma (ELOX)?

As of 04 Aug 2025, Eloxx Pharma (ELOX) is trading at a price of 0.04, with a previous close of 0.00. The stock has fluctuated within a day range of 0.04 to 0.04, while its 52-week range spans from 0.00 to 0.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.